Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Understanding Osteoporosis through Genetic Regulation of Stem Cell Differentiation
FY 2024-25
Summary
Osteoporosis is a disease that weakens the bones of millions of people worldwide, making them prone to fractures, chronic pain, and disability. It is primarily diagnosed by measuring bone mineral density (BMD), a key indicator of bone health. BMD is strongly influenced by genetics, and recent studies have identified hundreds of genetic regions (loci) linked to BMD. However, most are in parts of the genome that do not directly produce proteins (noncoding regions), so their exact roles and effects on genes are unknown. Understanding how these loci impact BMD will advance our understanding of osteoporosis and could reveal new ways to treat it. Bone-forming cells called osteoblasts play a crucial role in maintaining bone strength. Osteoblasts are derived from mesenchymal stem cells (MSCs), which can transform into various cell types. In osteoporosis, MSCs show a reduced ability to become osteoblasts, potentially contributing to weakened bones. Some BMD loci may alter MSC differentiation dynamics, reducing the number of osteoblasts. Research on mice has shown that changes in noncoding loci can impair osteoblast differentiation and bone health, highlighting the need to study how noncoding BMD loci influence MSCs. To address this, I will use CRISPR technologies to study the function of BMD loci in human MSCs. My first aim is to identify the impact of these loci on MSC gene activity by systematically disabling them and analyzing the resulting changes in each cell. My second aim is to determine how these loci affect MSCs ability to become osteoblasts by disrupting the loci during differentiation. These studies will reveal novel genetic mechanisms behind osteoporosis, identify potential high-priority drug targets, and advance therapies to restore bone health.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530173
Name
Thompson Kaiden J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding Osteoporosis through Genetic Regulation of Stem Cell Differentiation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bone Diseases; Cell Differentiation; Crispr Screens; Genetic Determinants Of Disease; Genome-Wide Association Studies; High-Throughput Screening; Human Genetics; Multi-Modal Sequencing; Single Cell Sequencing; Variant-To-Function
Abstract
Osteoporosis is a disease that weakens the bones of millions of people worldwide, making them prone to fractures, chronic pain, and disability. It is primarily diagnosed by measuring bone mineral density (BMD), a key indicator of bone health. BMD is strongly influenced by genetics, and recent studies have identified hundreds of genetic regions (loci) linked to BMD. However, most are in parts of the genome that do not directly produce proteins (noncoding regions), so their exact roles and effects on genes are unknown. Understanding how these loci impact BMD will advance our understanding of osteoporosis and could reveal new ways to treat it. Bone-forming cells called osteoblasts play a crucial role in maintaining bone strength. Osteoblasts are derived from mesenchymal stem cells (MSCs), which can transform into various cell types. In osteoporosis, MSCs show a reduced ability to become osteoblasts, potentially contributing to weakened bones. Some BMD loci may alter MSC differentiation dynamics, reducing the number of osteoblasts. Research on mice has shown that changes in noncoding loci can impair osteoblast differentiation and bone health, highlighting the need to study how noncoding BMD loci influence MSCs. To address this, I will use CRISPR technologies to study the function of BMD loci in human MSCs. My first aim is to identify the impact of these loci on MSC gene activity by systematically disabling them and analyzing the resulting changes in each cell. My second aim is to determine how these loci affect MSCs ability to become osteoblasts by disrupting the loci during differentiation. These studies will reveal novel genetic mechanisms behind osteoporosis, identify potential high-priority drug targets, and advance therapies to restore bone health.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Thompson, Kaiden J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~